The European Commission will sign a contract tomorrow for 300 million doses of a Covid19 vaccine that's more than 90% effective.
President Ursula von der Leyen says they plan to deploy the jab quickly to member states if it's approved.
Pfizer, which developed the vaccine, says no safety concerns have been raised since trials began.
European Commission spokesperson Eric Mamer, speaking through a translator, explains the process:
